Convulsive status epilepticus. Therapeutic protocol.
DOI:
https://doi.org/10.20344/amp.1155Abstract
Convulsive status epilepticus (CSE) in a medical emergency with a prognosis associated to its duration, claiming an early and effective treatment. The authors present the treatment protocol proposed at the Hospital de Santa Maria. The chosen definition of CSE allows its rapid treatment, and the electroencephalographic record the monitoring of its real efficacy. The treatment protocol is initiated whenever there are: continuous seizures persisting for more than 5 min, or two or more seizures surveying without regain of consciousness between them. The goal is stopping convulsive activity in less than 30 min and interrupting any epileptiform electroencephalographic activity. The initial pharmacological treatment of CSE includes lorazepam and fosphenitoin, a phenitoin prodrug. The first is chosen by the longer duration of its antiseizure effect as compared with diazepam; the second allows the administration of an identical dose but in a shorter period of time as compared to the mother drug; besides, it has few local and systemic effects and can be given intramuscularly after stopping the CSE. Drugs with a rapid clinical effect and rapid clearance, as midazolam and propofol should be used for treating refractory SE. Pentobarbital is the last anesthetic drug to be used because of its adverse cardiovascular effects and long-lasting action which can delay weaning from ventilatory support.Downloads
Downloads
Published
How to Cite
Issue
Section
License
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.